Skip to main content
padlock icon - secure page this page is secure

Immunomodulation, Part V: Probiotics

Buy Article:

$17.00 + tax (Refund Policy)

ACCORDING TO 2003 CENTERS for Disease Control and Prevention statistics, bacterial sepsis of the newborn is the eighth leading cause of death among neonates of all races and both sexes in the U.S., with a mortality rate of 18.9 per 100,000 live births, and necrotizing enterocolitis (NEC) is the thirteenth leading cause of death, with a mortality rate of 9.9 per 100,000 live births.1 Because these entities present such a significant public health challenge, researchers have been exploring various modalities, including immunomodulation, to enhance the neonatal immune system. Generally, the immunomodulators studied work through indirect stimulation or augmentation of the immune system.

No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Publication date: January 1, 2007

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more